Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polysomnographic comparison of oxycodone/naloxone prolonged release versus pramipexole for idiopathic restless legs syndrome
2014-000140-15Phase 2Terminated
- Sponsor
- Fondazione Neureca
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of oxycodone and pramipexole in restless legs syndrome (RLS) (2 arms), sponsored by Fondazione Neureca. Primary endpoint: Sleep efficiency. Started Sep 2014; status: terminated.
02
Drugs
oxycodonepramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2014-000140-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000140-15.